Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24498853

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
BMC Cancer
Publication date
2014 Feb 5
First author
Lindemann K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lindemann K
      type
      Author
    2. name
      Malander S
      type
      Author
    3. name
      Christensen RD
      type
      Author
    4. name
      Mirza MR
      type
      Author
    5. name
      Kristensen GB
      type
      Author
    6. name
      Aavall-Lundqvist E
      type
      Author
    7. name
      Vergote I
      type
      Author
    8. name
      Rosenberg P
      type
      Author
    9. name
      Boman K
      type
      Author
    10. name
      Nordstrøm B
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lindemann K
      type
      Author
    2. name
      Malander S
      type
      Author
    3. name
      Christensen RD
      type
      Author
    4. name
      Mirza MR
      type
      Author
    5. name
      Kristensen GB
      type
      Author
    6. name
      Aavall-Lundqvist E
      type
      Author
    7. name
      Vergote I
      type
      Author
    8. name
      Rosenberg P
      type
      Author
    9. name
      Boman K
      type
      Author
    10. name
      Nordstrøm B
      type
      Author
    bibliography ids
    1. nci-bib-332559af2e87390d12f511bc
    book metadata
    content sha256
    7bdfea65c07b7309ee58161bcacda4818e1155c1464fb4003adee050409f2b6f
    document type
    citation
    dois
    1. 10.1186/1471-2407-14-68
    electronic publication date
    display
    2014 Feb 5
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24498853
    immutable id
    pubmed:24498853@7bdfea65c07b7309ee58161bcacda4818e1155c1464fb4003adee050409f2b6f
    journal
    abbreviation
    BMC Cancer
    issn electronic
    1471-2407
    issn print
    Source null
    issue
    Source null
    name
    BMC cancer
    nlm unique id
    100967800
    pages
    68
    volume
    14
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24498853
      provenance
      batch id
      af10498814d931b53231
      provider
      NCBI PubMed ESummary
      record sha256
      8c4fcb5da38f29dad827f99ddabe4a582e811a867de5af9073a83c3653a42f7f
      response sha256
      077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
      retrieved at
      2026-09-09T23:47:00.193465+00:00
      publication date
      display
      2014 Feb 5
      precision
      day
      year
      2014
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24498853/
      title
      Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).

      Preserved source evidence · Not medical advice